This Site
Web Search
powered by
YAHOO! SEARCH
Mobile Edition
RSS
Home
News
Community News
Education
Elections
Crime
Gangs
Mexican Veterans
Portraits of the Fallen
Graduations
Health
Sports
Preps
Youth Sports
Area Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Kings
Ducks
Soccer
Motorsports
Live Odds
Scores/Stats
Business
Technology
Financial Markets
Opinions
Editorial
Letters
Columnists
Blogs
Write a Letter
LA.COM
Celebs & Gossip
Movies
TV
Music
Arts
Dining
Nightlife
Shopping & Beauty
Weekend
Comics
Games
Lottery
Horoscopes
Today
Taste
Getting Out
At Home
Info
Contact Us
RSS
Site Map
Subscriber Services
Search Archives
Place An Ad
NIE
Local Biz Center
Obituaries
Homes
Search Homes
Place an Ad
Autos
Search Autos
Place an Ad
Jobs
Find a Job
Post a Job
Classifieds
Search Classfieds
Place an Ad
San Gabriel Valley
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Sanofi-Aventis ADS
(NY:
SNY
)
55.05
USD
+1.21 (+2.25%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
1,564,015
Open
54.32
Bid (Size)
54.99 (100)
Ask (Size)
55.02 (300)
Prev. Close
53.84
Today's Range
54.19 - 55.05
52wk Range
0.1000 - 55.69
Shares Outstanding
2,681,837,622
Dividend Yield
3.07%
Top News
More News
New Asthma Drug Generates Excitement For Patients -- And Its Maker
Today 8:52 EDT
Read More
category
NYSE:MRK
,
NYSE:SNY
,
NASDAQ:REGN
, and 1 more.
from
Forbes Real Time
Sanofi (SNY), Regeneron (REGN) Report Publication of Positive Dupilumab Phase 2a Data
Today 8:16 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8357210 for the full story.
Read More
from
StreetInsider.com News Articles
More News
Read More
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
Today 8:15 EDT
from
PR Newswire
New Asthma Drug Could Be Game Changer
Today 6:45 EDT
category
NYSE:SNY
,
NASDAQ:REGN
,
Hot Stocks
from
InvestorPlace - Latest Headlines
Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation
Today 2:00 EDT
from
Business Wire News Releases
Microsoft (MSFT) Flat Into Reveal of Next-Gen Xbox
May 20, 2013
from
StreetInsider.com News Articles
Sanofi (SNY) Reports JAKARTA Met Primary Endpoint in Both Groups
May 17, 2013
from
StreetInsider.com News Articles
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
May 17, 2013
from
PR Newswire
Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month
May 16, 2013
from
PR Newswire
Finding the Next Big Blockbuster Drug
May 15, 2013
from
ACCESSWIRE
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
RSS